Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 175,766
  • Shares Outstanding, K 43,399
  • Annual Sales, $ 112,250 K
  • Annual Income, $ -3,420 K
  • 60-Month Beta 1.43
  • Price/Sales 1.66
  • Price/Cash Flow 18.77
  • Price/Book 2.51
Trade HBIO with:

Options Overview Details

View History
  • Implied Volatility 79.36% ( +48.99%)
  • Historical Volatility 60.33%
  • IV Percentile 64%
  • IV Rank 36.48%
  • IV High 210.78% on 03/07/24
  • IV Low 3.89% on 03/27/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 70
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 164
  • Open Int (30-Day) 136

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.84 +8.07%
on 03/18/24
4.61 -9.88%
on 03/07/24
-0.37 (-8.19%)
since 02/16/24
3-Month
3.84 +8.07%
on 03/18/24
5.56 -25.36%
on 12/28/23
-0.75 (-15.31%)
since 12/18/23
52-Week
2.85 +45.74%
on 03/21/23
6.29 -34.02%
on 05/02/23
+1.14 (+37.87%)
since 03/17/23

Most Recent Stories

More News
Harvard Bioscience: Q4 Earnings Snapshot

Harvard Bioscience: Q4 Earnings Snapshot

HBIO : 4.15 (+2.47%)
Harvard Bioscience: Q3 Earnings Snapshot

Harvard Bioscience: Q3 Earnings Snapshot

HBIO : 4.15 (+2.47%)
Harvard Bioscience: Q2 Earnings Snapshot

Harvard Bioscience: Q2 Earnings Snapshot

HBIO : 4.15 (+2.47%)
What Makes Harvard Bioscience (HBIO) a Good Fit for 'Trend Investing'

Harvard Bioscience (HBIO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

HBIO : 4.15 (+2.47%)
Why Harvard Bioscience Stock Rose This Week

The company reported improved revenue in Q1.

HBIO : 4.15 (+2.47%)
Harvard Bioscience: Q1 Earnings Snapshot

Harvard Bioscience: Q1 Earnings Snapshot

HBIO : 4.15 (+2.47%)
Harvard Bioscience: Q4 Earnings Snapshot

Harvard Bioscience: Q4 Earnings Snapshot

HBIO : 4.15 (+2.47%)
Harvard Bioscience (HBIO) Reports Q3 Loss, Misses Revenue Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -120% and 3.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HBIO : 4.15 (+2.47%)
ZS : 195.94 (+0.98%)
Harvard Bioscience: Q3 Earnings Snapshot

Harvard Bioscience: Q3 Earnings Snapshot

HBIO : 4.15 (+2.47%)
Harvard Bioscience Announces Second Quarter 2022 Financial Results

HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the...

HBIO : 4.15 (+2.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

See More

Key Turning Points

3rd Resistance Point 4.81
2nd Resistance Point 4.56
1st Resistance Point 4.35
Last Price 4.15
1st Support Level 3.89
2nd Support Level 3.64
3rd Support Level 3.43

See More

52-Week High 6.29
Fibonacci 61.8% 4.97
Fibonacci 50% 4.57
Fibonacci 38.2% 4.16
Last Price 4.15
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar